Suppr超能文献

心血管药物和抗炎药物对噻嗪类药物诱导的血流动力学和利钠作用的影响。

The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects.

作者信息

Knauf H, Bailey M A, Hasenfuss G, Mutschler E

机构信息

Department of Medicine 1, St. Berward-Krankenhaus, Hildesheim, Germany.

出版信息

Eur J Clin Pharmacol. 2006 Nov;62(11):885-92. doi: 10.1007/s00228-006-0190-3. Epub 2006 Sep 9.

Abstract

OBJECTIVE

Thiazide diuretics are known to induce a transient fall of the glomerular filtration rate (GFR), which, in turn, reduces tubular Na(+) load. This tubuloglomerular feedback (TGF) curtails the natriuretic effect of this class of diuretics. Cardiovascular and antiinflammatory therapeutics may interfere with TGF and thereby influence the effect of thiazides once co-administration is clinically indicated.

METHODS

The effects on GFR and saluresis of hydrochlorothiazide (HCT; 25 mg) monotherapy were measured in healthy volunteers and compared to those obtained during co-administration of the thiazide and a second therapeutic.

RESULTS

In the presence of the ACE inhibitor enalapril (10 mg), the transient fall in the GFR induced by HCT was almost abolished, and Na(+) excretion increased by approximately 30 % as compared to HCT monotherapy. K(+) excretion, however, remained unchanged. Similar results were obtained with the AT II type 1 receptor antagonist candesartan (8 mg): GFR remained stable, Na(+) excretion rose by 35 % and K(+) excretion was not changed. The effect of the Ca(2+) channel blocker amlodipine (5 mg) on GFR and HCT-induced Na(+) excretion equalled that obtained with the AT(1) blocker, yet with this treatment K(+) excretion rose in proportion to Na(+) excretion. The beta-blockers propranolol (80 mg) or bisoprolol (5 mg) reduced GFR but maintained TGF. HCT-induced Na(+) excretion was significantly reduced in the presence of a beta-blocker, whereas K(+) excretion was not changed. The inhibition of cyclooxygenase by diclofenac (50 mg) or rofecoxib (25 mg) significantly reduced the diuretic/natriuretic effect of HCT, but K(+) excretion was unchanged, and TGF was still demonstrable.

CONCLUSION

In conclusion, AT(1) receptors, as well as the Ca(2+) channels in the smooth muscle cells of the afferent arteriole, are considered prerequisites for TGF function; their blockade increases the diuretic/natriuretic efficacy of thiazide diuretics. In contrast, beta-blockers and COX inhibitors do not interfere directly with TGF. These first dose effects reflect the primary response of the kidney to the drugs. They cannot, however, predict the benefits of long-term treatment.

摘要

目的

已知噻嗪类利尿剂会导致肾小球滤过率(GFR)短暂下降,这反过来又会降低肾小管钠(Na⁺)负荷。这种肾小管 - 肾小球反馈(TGF)会削弱这类利尿剂的利钠作用。一旦临床表明需要联合用药,心血管和抗炎治疗药物可能会干扰TGF,从而影响噻嗪类药物的疗效。

方法

在健康志愿者中测量氢氯噻嗪(HCT;25mg)单药治疗对GFR和尿钠排泄的影响,并与噻嗪类药物与另一种治疗药物联合使用时获得的结果进行比较。

结果

在存在血管紧张素转换酶抑制剂依那普利(10mg)的情况下,HCT诱导的GFR短暂下降几乎被消除,与HCT单药治疗相比,Na⁺排泄增加了约30%。然而,钾(K⁺)排泄保持不变。使用1型血管紧张素II受体拮抗剂坎地沙坦(8mg)也得到了类似的结果:GFR保持稳定,Na⁺排泄增加35%,K⁺排泄未改变。钙(Ca²⁺)通道阻滞剂氨氯地平(5mg)对GFR和HCT诱导的Na⁺排泄的影响与AT₁受体阻滞剂相当,但在这种治疗下,K⁺排泄与Na⁺排泄成比例增加。β受体阻滞剂普萘洛尔(80mg)或比索洛尔(5mg)降低了GFR,但维持了TGF。在存在β受体阻滞剂的情况下,HCT诱导的Na⁺排泄显著减少,而K⁺排泄未改变。双氯芬酸(50mg)或罗非昔布(25mg)对环氧化酶的抑制显著降低了HCT的利尿/利钠作用,但K⁺排泄未改变,且TGF仍然存在。

结论

总之,AT₁受体以及入球小动脉平滑肌细胞中的Ca²⁺通道被认为是TGF功能的先决条件;它们的阻断增加了噻嗪类利尿剂的利尿/利钠功效。相比之下,β受体阻滞剂和环氧化酶抑制剂不会直接干扰TGF。这些首剂效应反映了肾脏对药物的初始反应。然而,它们无法预测长期治疗的益处。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验